financetom
Business
financetom
/
Business
/
Centessa Pharmaceuticals Appoints John Crowley as CFO
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Centessa Pharmaceuticals Appoints John Crowley as CFO
Jun 10, 2024 5:13 AM

07:55 AM EDT, 06/10/2024 (MT Newswires) -- Contessa Pharmaceuticals (CNTA) said on Monday it had appointed John Crowley to succeed Gregory Weinhoff as Chief Financial Officer, effective June 10.

The company said Weinhoff will continue serving the company in the newly created role of Chief Business Officer.

Crowley served as Chief Financial Officer of Fusion Pharmaceuticals before AstraZeneca acquired it in June 2024.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Update: Nvni Group Regains Nasdaq Compliance; Shares Jump Premarket
Update: Nvni Group Regains Nasdaq Compliance; Shares Jump Premarket
Jan 24, 2025
05:07 AM EST, 01/24/2025 (MT Newswires) -- (Updates with the stock move in the headline and the last paragraph.) Nvni Group ( NVNI ) said late Thursday that it regained compliance with Nasdaq's minimum closing bid price requirement for continued listing. The company's shares were up over 24% in premarket activity Friday. Price: 1.85, Change: +0.36, Percent Change: +24.16 ...
Ericsson Q4 Earnings, Net Sales Increase
Ericsson Q4 Earnings, Net Sales Increase
Jan 24, 2025
05:15 AM EST, 01/24/2025 (MT Newswires) -- Ericsson (ERIC) reported Q4 earnings Friday of 1.44 Swedish krona ($0.13) per diluted share, up from 1.02 krona a year earlier. Analysts polled by FactSet expected 2.18 krona. Net sales for the quarter ended Dec. 31 were 72.9 billion krona, up from 71.9 billion krona a year earlier. Analysts surveyed by FactSet expected...
BNP Paribas' ESG rethink to focus on profitable sustainable finance
BNP Paribas' ESG rethink to focus on profitable sustainable finance
Jan 24, 2025
* US-led political backlash has driven banks' ESG retreat * BNP to focus on four themes in sustainable finance * Bank survey found people want to invest thematically By Virginia Furness LONDON, Jan 24 (Reuters) - BNP Paribas is rethinking sustainable finance to focus on profitable deals and on redefining what it considers sustainable, a senior executive said, as it...
Allurion Technologies Soars Premarket After Unveiling Plans for Combination Therapy Trial to Optimize Muscle Mass
Allurion Technologies Soars Premarket After Unveiling Plans for Combination Therapy Trial to Optimize Muscle Mass
Jan 24, 2025
05:28 AM EST, 01/24/2025 (MT Newswires) -- Allurion Technologies ( ALUR/WS ) shares surged more than 81% premarket Friday after the company said overnight that it plans to initiate a combination clinical study to improve muscle mass and overall body composition. The clinical trial will combine the Allurion Program, a weight-loss platform, with GLP-1 agonists. The latter are primarily used...
Copyright 2023-2026 - www.financetom.com All Rights Reserved